Holen Sie sich die Stockscreener-App
4.93
9.04%
-0.49
Handel nachbörslich:
4.95
0.02
+0.41%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$5.42
Offen:
$5.37
24-Stunden-Volumen:
2.69M
Relative Volume:
1.08
Marktkapitalisierung:
$2.00B
Einnahmen:
$9.47B
Nettoeinkommen (Verlust:
$-178.00M
KGV:
-10.27
EPS:
-0.48
Netto-Cashflow:
$1.01B
1W Leistung:
-8.87%
1M Leistung:
-7.50%
6M Leistung:
-49.12%
1J Leistung:
-36.96%
1-Tages-Spanne:
$4.9212
$5.385
1-Wochen-Bereich:
$4.9212
$5.595
52-Wochen-Spanne:
$3.96
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Vergleichen Sie BHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
4.93 | 2.00B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
158.06 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.38 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.63 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.39 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.70 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Bausch Health price target cut to $8 by Raymond James - Investing.com UK
Dry Eye Syndrome Treatment Market Set to Witness Significant - openPR.com
BHC: RBC Capital Raises Price Target for Bausch Health Companies | BHC Stock News - GuruFocus
Bausch Health Companies Inc. (NYSE:BHC) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Humana (HUM) and Larimar Therapeutics (LRMR) - The Globe and Mail
Bausch Health Companies First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Psoriasis Market: Epidemiology, Therapies, Companies, - openPR.com
RBC on Bausch Health's Q1 - marketscreener.com
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down - The Globe and Mail
Bausch Health Companies Inc. SEC 10-Q Report - TradingView
Bausch Health Reports Q1 2025 Financial Results - TipRanks
Bausch Health Companies Q1 2025 Earnings Call Transcript - MarketBeat
Bausch: Q1 Earnings Snapshot - MySA
Bausch Health (BHC) Q1 Earnings and Revenues Lag Estimates - Yahoo Finance
Bausch (BHC) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Bausch Health Companies Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Bausch Health Q1 2025 slides: revenue up 6%, EBITDA grows 14% excluding B+L - Investing.com
Bausch Health Companies Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:BHC) - Seeking Alpha
Bausch Health Down 3.8% After Hours as It Reports a Lower Q1 Adjusted Profit - marketscreener.com
Bausch Health Reports Strong Q1 2025 Results with Revenue Growth and Strategic Refinancing - TipRanks
Bausch Health (BHC) Pre-Earnings Options Activity Indicates Anti - GuruFocus
Bausch Health Reports 8th Consecutive Growth Quarter, Completes $7.9B Refinancing Deal - Stock Titan
Bausch Health Announces First Quarter 2025 Results - The Globe and Mail
Bausch + Lomb Brief: Updating FY25 Guidance to Reflect Estimated One-Time Impact of enVista Intraocular Lenses Voluntary Recall and Impact of FX - marketscreener.com
Health Canada approves Bausch Health’s skin tightening device - Investing.com
Bausch Health Companies Q1 2025 Earnings Preview - MSN
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Bausch Health Companies Inc. (BHC) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Hyperopia Market, Epidemiology, Therapies, Companies, - openPR.com
Bausch Health's Skin Tightening System Gets Health Canada Clearance - marketscreener.com
BHC Receives Canadian Approval for Advanced Thermage FLX Device - GuruFocus
Bausch Health Announcing Health Canada Clearance of Solta Medical's Thermage FLX System - marketscreener.com
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System - voiceofalexandria.com
Revolutionary Skin Tightening Device Thermage FLX Gets Health Canada Green Light: 25% Faster Treatments - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Onychomycosis Drug Market Emerging Trends and Growth Prospects - openPR.com
Bausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding Shares - MSN
Bausch Health jumps after Carl Icahn’s 34% stake - MSN
BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc. - ACCESS Newswire
Bausch Health unveils new skin resurfacing laser at ASLMS 2025 - Investing.com
Bausch Health unveils new skin resurfacing laser at ASLMS 2025 By Investing.com - Investing.com Canada
Future of Eye Health: Macular Degeneration Treatment Market - openPR.com
Bausch Health (BHC) Set to Launch Next-Gen Fraxel FTX at Key Con - GuruFocus
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM) - Weatherford Democrat
Facial Rejuvenation Market Report 2025-2034: Industry - openPR.com
Bausch Health says Carl Icahn has exposure to about 34% of company's shares - MSN
Bausch Health Learns Icahn Has 34% Economic Interest in Shares - MSN
Is Bausch Health Companies Inc. (BHC) the Best Canadian Penny Stock to Invest in Now? - Insider Monkey
Bausch Health (BHC) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):